Form 4: Natera Executive Solomon Moshkevich Sells Shares to Cover Tax Obligations

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold a portion of his common stock to cover tax withholding obligations related to vesting RSUs.

Summary

• On March 17, 2025, Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,023 shares of common stock at $146.0277 per share and 3 shares at $149.74 per share.
• The sales were executed to satisfy tax withholding and remittance obligations related to the vesting of Restricted Stock Units (RSUs).
• These transactions were made pursuant to a pre-arranged written instruction intended to comply with Rule 10b5-1(c) under the Exchange Act, as part of the Reporting Person's Stock Unit Agreement granted on March 12, 2025.
• Following the reported transactions, Moshkevich beneficially owns 144,782 shares of Natera common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes on vested RSUs) and doesn't convey strong positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations on vesting RSUs are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the reason for the sale.

Key Dates

Keywords

Natera, NTRA, Form 4, Moshkevich, Solomon Moshkevich, Insider Trading, Stock Sale, RSUs, Rule 10b5-1(c), Tax Obligations, Clinical Diagnostics